Advanced search×

The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.

Daren A DA Scroggie, Allison A Albright, and Mark D MD Harris

Arch Intern Med 163(13):1587-90 (2003) PMID 12860582

With increasing use of glucosamine-containing supplements for the treatment of osteoarthritis, there is increasing concern in the medical community about possible toxic effects. The present study was undertaken to determine whether glucosamine supplementation altered hemoglobin A1c concentrations in patients with well-controlled diabetes mellitus.

DOI: 10.1001/archinte.163.13.1587
Version: za2963e q8zaf q8zbb q8zca q8zdf q8ze0 q8zfb q8zg6

Similar articles you may find interesting…

  1. Clinical implications of MET gene copy number in lung cancer.
    Luca L Toschi and Federico F Cappuzzo

    Per Med 6(2):239-47 (2010) PMID 20146583

    MET, the receptor for HGF, has recently been identified as a novel promising target in several human malignancies, including non-small-cell lung cancer (NSCLC). Deregulation of the HGF/MET signaling pathway can occur via different mechanisms, including HGF and/or MET overexpression, MET gene amplifi...
  2. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.
    A A Peasland, L-Z LZ Wang, ... N J NJ Curtin

    Br J Cancer 105(3):372-81 (2011) PMID 21730979 PMCID PMC3172902

    NU6027 is a potent inhibitor of cellular ATR activity (IC(50)=6.7 μM) and enhanced hydroxyurea and cisplatin cytotoxicity in an ATR-dependent manner. NU6027 attenuated G2/M arrest following DNA damage, inhibited RAD51 focus formation and increased the cytotoxicity of the major classes of DNA-damag...
    View PDF
  3. Effect of admission medication reconciliation on adverse drug events from admission medication changes.
    Kenneth S KS Boockvar, Sharon S Blum, ... Jessica J Yeh

    Arch Intern Med 171(9):860-1 (2011) PMID 21555668